SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ImmunityBio converts from Immunomedics
An SI Board Since February 2023
Posts SubjectMarks Bans Symbol
1558 51 0 IBRX
Emcee:  TinfoilHat Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
467Aside from being exploratory in nature, this basket trial seems to be designed fghettogoulash-4/30/2024
466Would not copy and paste correctly but It looks like Total short ratio is 51.81%zagnut1-4/30/2024
465" Also on the topic of Ph3, the current path for NSCLC in 2nd or 3rd is End2War-4/29/2024
464Does anyone know how many shares are still short after today? Thanks in advancezagnut1-4/29/2024
463I'm glad to hear that about "pipeline in an asset." Such is the caghettogoulash14/29/2024
462Damn! I knew that iborrow.com gets its numbers from IB, but always wondered if tghettogoulash-4/29/2024
461I don't pay attention to TA, but that run to $40 was the newbies vaping covighettogoulash-4/29/2024
460Full disclosures: I took about a third off the table today. Still own way to mucmannamal-4/29/2024
459I've been with Etrade (brokerage, checking, savings, etc etc) for decades buerippetoe-4/29/2024
458Someone said they were moving money to a new account. Highly recommend InteractTinfoilHat14/29/2024
457The borrow rate at Etrade from 4/26 is 42.186% fwiw...erippetoe-4/29/2024
456If this is following a familiar pattern, then most of this steep rise is the “duOlecranon14/29/2024
455Meanwhile, top 10 trending on wall street bets. Put that in your pipe and smoke TinfoilHat-4/29/2024
454Piper Sandler analyst Joseph Catanzaro maintains ImmunityBio(IBRX) with a Neutraluckydog88-4/29/2024
453Ha, no not mad at all. Someone else posted about me smoking weed from my bong, ITinfoilHat54/29/2024
452Collaboration with Merck would certainly benefit both parties, but I'm thinkghettogoulash-4/29/2024
451I know you're just being you, but it was actually Kyborg who made me realizeghettogoulash-4/28/2024
450Otherwise Anktiva could just be prescribed with a biosimilar, right?ghettogoulash-4/28/2024
449I'm guessing Merck's ultimate plan is to file a secondary patent, affectghettogoulash-4/28/2024
448Thank you twins. Found it and will watch it in a bit...may be adding a few morerecarte-4/28/2024
4473rd world diarrhea hahaghettogoulash-4/28/2024
446recarte. Just Google ImmunityBio conference call and take it to the IBRX websitbobbseytwins200164/28/2024
445Now I know why PSS keeps emphasizing patent cliffs. Regarding pricing, this didnghettogoulash-4/28/2024
444I, for the life of me, cannot find the link to the Friday presentation. Does anrecarte-4/28/2024
443I found PSS reference to " naive " use to be serious potential changeurslor-4/28/2024
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News